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Abstract
Background: This study aimed to compare the histological and immunohistochemical characteristics of amelo-
blastomas (AM) and ameloblastic carcinomas (AC). 
Material and Methods: Fifteen cases of AM and 9 AC were submitted to hematoxilin and eosin (H&E) and im-
munohistochemical analysis with the following antibodies: cytokeratins 5,7,8,14 and 19, Ki-67, p53, p63 and the 
cellular adhesion molecules CD138 (Syndecan-1), E-cadherin and β-catenin. The mean score of the expression 
of Ki-67 and p53 labelling index (LIs) were compared between the groups using the t test. A value of p<0.05 was 
considered to be statistically significant.  
Results: All cases were positive for CKs 5, 14 and 19, but negative for CKs 7 and 8. CKs 5 and 19 were positive 
mainly in the central regions of the ameloblastic islands, while the expression in AC was variable in intensity and 
localization. CK14 was also variably expressed in both AM and AC. Ki-67 (P=.001) and p53 (P=.004) immuno-
expression was higher in AC. All cases were positive for p63, but values were higher in AC. CD138 was mainly 
expressed in peripheral cells of AM, with a weak positivity in the central areas, while it was positive in most areas 
of ACs, except in less differentiated regions, where expression was decreased or lost. E-cadherin and β-catenin 
were weakly positive in both AM and AC. 
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Introduction
Ameloblastoma (AM) is one of the most common benign 
odontogenic neoplasms of the jaws, affecting mainly the 
posterior region of the mandible. It is locally aggressive, 
with a high rate of recurrence, while ameloblastic car-
cinoma (AC) is considered its malignant counterpart. 
Although rare, with less than 120 cases reported in the 
English literature, AC is the most common malignant 
odontogenic tumor (1). Microscopically it may show ar-
eas reminiscent of ameloblastoma, but with an invasive 
and less organized pattern, presenting atypia, mitoses 
and loss of typical ameloblastic morphology (2). Diag-
nosis of AC sometimes can be difficult, and both, clini-
cal and histopathological features should be considered. 
The aim of this study was to compare the microscopic 
and immunohistochemical characteristics of 9 cases of 
AC and 15 of AM to determine the pattern of expression 
or differences in location or intensity of expression that 
may be of assistance in their differentiation.
Material and Methods
Fifteen cases of solid/multicystic AM and 9 AC were 
retrieved from the files of 5 Latin American oral pathol-
ogy diagnostic services (Piracicaba Dental School, Bra-
zil; Head and Neck Clinical Center, Guatemala; Peri-
bact Private Service of Oral Pathology, Mexico; Oral 
Pathology Laboratory of the Universidad Autonoma 
Metropolitana Xochimilco, Mexico, and Oral Pathol-
Conclusions: These results shows that Ki-67, p53 and p63 expression was higher in AC as compared to AM, sug-
gesting that these markers can be useful when considering diagnosis of malignancy, and perhaps could play a role in 
malignant transformation of AM. Pattern of expression of CKs 5 and 19 in AC were different to those found in AM, 
suggesting genetic alterations of these proteins in malignant cells. It was confirmed that CK19 is a good marker for 
benign odontogenic tumors, such as AM, but it is variably expressed in malignant cases.
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Antibody Clone Dilution Source 
CK5 XM26 1:400 Novocastraa
CK7 OV-TL 12/30 1:300 Dakob
CK8 CXL3 1:400 Novocastraa
CK14 LL 002 1:200 Novocastraa
CK19 RCK 108 1:200 Dakob
Ki-67 MIB-1 1:100 Dakob
p53 DO-7 1:200 Dakob
p63 4A4 1:300 Dakob
CD138
(Syndecan-1) 
MI15 1:100 Dakob
E-cad 36B5 1:200 Novocastraa
E-cat  17C2 1:200 Novocastraa
Table 1: Antibodies used for immunohistochemical evaluation of 15 cases of 
ameloblastomas and 9 cases of ameloblastic carcinomas.
a Novocastra, Newcastle Upon Tyne, UK.
b Dako, Dako Corporation, Carpintería, Calif.
ogy Laboratory of the Universidad Peruana Cayetano 
Heredia, Peru). Clinical and radiographic data were re-
trieved from the patient s´ files when available. Histo-
logical hematoxylin and eosin (H&E) stained sections 
of all cases were reviewed and diagnosis confirmed ac-
cording to the current WHO Histological Classification 
of Tumors (3). For immunohistochemical analysis the 
following antibodies were used: cytokeratins 5,7,8,14 
and 19, Ki-67, p53, p63 and the cellular adhesion mol-
ecules CD138 (Syndecan-1), E-cadherin and β-catenin 
(Table 1). For immunohistochemical staining 3µm sec-
tions of each case were used. Briefly, after antigen re-
trieval with EDTA/Tris buffer (pH 9.0) in a microwave 
oven, endogenous peroxidase activity was blocked with 
20% H2O2. After overnight incubation, primary anti-
bodies were detected by secondary antibodies labeled 
with estreptavidin-biotin-peroxidase, and the reaction 
developed with diaminobenzidine hydrochloride (DAB, 
Dako). The preparations were lightly counterstained 
with Carazzi hematoxylin, mounted with Canada bal-
sam and examined by light microscopy. Immunohisto-
chemical results were graded as negative (-) or positive 
(+). Labeling index (LI) estimated with Ki-67 and p53 
nuclear positiveness were evaluated in 5 selected epi-
thelial areas that showed higher cellular density, using 
a 20X objective, and expressed in percentage using the 
ScanerScope System (Nuclear V9). The mean score of 
the expression of Ki-67 and p53 LIs were compared be-
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tween the groups using the t test. A value of p<0.05 was 
considered to be statistically significant. This work was 
approved by the Ethics Committee in Research of the 
Piracicaba Dental School, University of Campinas, Bra-
zil (registration number 120/2013).
Results
Among the 15 cases of AM there were 9 males and 6 
females; age ranged from 11-58 yr. (mean age: 33.60 
yr.). Nine cases involved the posterior mandible, and 
histologically all were of the solid type, 12 with pre-
dominant plexiform and 3 with follicular patterns. The 
stroma was variably collagenized, and in 4 cases it was 
focally myxoid.
Ki-67 was mainly positive in some cells of the basal and 
suprabasal layers, but only occasional cells in the cen-
tral areas similar to the stellate reticulum of the enamel 
organ were marked. The proliferative index varied be-
tween 0.35% and 6.89% with a mean of 2.37% (Fig. 1a). 
The localization and percentage of p53 immunostain-
ing were similar to Ki-67, but it was less intense, with 
values of positive nuclei between 0.13% and 5.90% and 
a mean of 1.77% (Fig. 1b). p63 was positive mainly in 
the columnar cells of  the peripheral layer of the islands/
cords while in the central areas staining was variable, 
except for those areas of squamous metaplasia, which 
were positive  in most cases (Fig. 1c). 
Regarding CKs expression, CK5 appeared more in-
tensely expressed in the central stellate reticulum-like 
areas than in the basal columnar cells, and it was posi-
tive in islands presenting flattened cells in both the pe-
ripheral and central areas (Fig. 1d), while in areas of 
squamous metaplasia it was variably expressed. CK14 
expression was weak and diffuse in most cases, and 
Fig. 1: Main immunohistochemical features in ameloblastoma: a. Ameloblastoma showing the nuclei of a few cells 
of the basal and suprabasal layers positive for Ki-67 (200X), b. Nuclear expression of p53 in AM, positive cells are 
evident, but the intensity of the staining is weak- arrows (200X), c. p63 immunostaining in ameloblastomas, showing 
epithelial islands intensely positive mainly in the peripheral cells, but many of the central cells also expressed this 
marker (200X), d. The central areas of the islands/cords were strongly positive for CK5, while the expression was 
weaker or negative on the peripheral columnar cells (200X), e. Follicular islands showing stronger expression in the 
central areas, but the basal layer was also positive. Arrow shows squamous metaplasia with cells weakly positive 
(200X), f. CK19 immunostaining in ameloblastoma, showing central cells intensely positive, with weak or negative 
expression in the basal and suprabasal layers (400X), g. Higher magnification of an epithelial island illustrating posi-
tiveness of CD138 mainly in the basal and suprabasal layers. Arrow shows squamous metaplasia, with peripheral cells 
exhibiting strong positivity, with the more central squamous cells loosening expression (400X), h. Central areas of an 
epithelial ameloblastic sheet showing positivity in cells presenting characteristics of squamous metaplasia (400X), i. 
Case of AM showing strong positiveness for β-catenin mainly in the peripheral columnar cells, loosing expression in 
some central cells. This strong staining was not common, as in most of the cases the labeling with β-catenin was weak 
or practically negative (200X). 
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positiveness was mainly found in the stellate reticulum-
like areas (Fig. 1e), but also in the basal layer of cystic 
areas, and it was weakly positive in some of the most 
superficial cells. CK19 showed strong expression in the 
central cells of the cords/islands, but it was weak or neg-
ative in the peripheral columnar cells (Fig. 1f). All cases 
of AM were negative for CK7 and CK8. 
Among the adhesion molecules evaluated, CD138 was 
the most strongly expressed, particularly in the basal 
and suprabasal layers, while areas of squamous meta-
plasia were negative or weakly positive, while most 
central stellate reticulum-like cells were negative (Fig. 
1g). E-cadherin expression in AM was not as evident as 
CD138, and in some cases staining was faint or practi-
cally negative. The basal and suprabasal cells exhibited 
a higher positivity than those located in the central ar-
eas. In some cases, groups of cells presenting squamous 
metaplasia were strongly positive, particularly when 
cell junctions were evident in H&E (Fig. 1h). β-catenin 
was the least expressed of the three adhesion markers 
used, being weakly positive in most cases, except in ar-
eas with squamous metaplasia, where expression was 
more evident (Fig. 1i). 
With respect to the 9 cases of AC, there were 5 males 
and 4 females, with a mean age of 43.67 years (range: 
22-65 years). The mandible was involved in 8 cases, 7 
in the posterior region, and only one case occurred in 
the maxilla (Fig. 2). All cases were solid, with only one 
showing cystic areas. Most cases were composed by 
sheets of cells arranged in a plexiform pattern, but in 2 
cases a follicular pattern predominated. The malignant 
epithelial cells showed pleomorphism and mitoses, and 
in six cases there were evidence of focal areas of necro-
sis. Some islands showed central areas similar to the 
stellate reticulum of the enamel organ, and most cases 
contained areas reminiscent of benign ameloblastoma 
but these were exceeded by the malignant component. 
The stroma usually was scarce and collagenized (Fig. 
3). 
Ki-67 proliferative index in AC ranged from 11.87% 
to 53.29% (mean: 23.46%), with positiveness in both 
peripheral and central cells (Fig. 4a). Regions similar 
to benign ameloblastoma exhibited a lower expression 
of Ki-67, but these were not included for quantitation. 
The distribution of cells positive for p53 was similar 
as above described for Ki-67, but the nuclei were much 
less intensely stained, with percentages of positive cells 
varying from 11.57% to 80.88% (mean: 36.01%) (Fig. 
4b). p63 expression was strongly positive in most cases 
and in most cells (Fig. 4c). 
Expression of CK5 in AC was variable, as in 7 cases it 
was strongly positive either at the periphery or within 
Fig. 2: Most cases of ameloblastic carcinoma involved the posterior mandible. This figure illustrates two 
unusual cases, one involving the anterior mandible and the other the left maxilla, a. Panoramic radiography 
showing irregular radiolucent lesion involving the anterior mandible causing tooth displacement, mobility and 
loss, b. AC of left maxilla affecting the alveolar ridge and extending into the palate. The perforation in the 
mucosa corresponds to a recent tooth extraction, c. Radiograph of the same case showing radiolucent image 
involving the left maxillary sinus and adjacent areas, including floor of the orbit. 
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Fig. 3: Histological features of ameloblastic carcinoma, a. Epithelial islands with artefactual empty central spaces 
showing a follicular pattern, resembling an ameloblastic epithelium with columnar peripheral cells. The stroma is 
highly collagenized (H&E, 400X), b. Sheets of malignant epithelial cells showing a peripheral layer formed by colum-
nar cells, with ameloblastic characteristics, including reversal nuclear polarization. Cellular pleomorphism and atypi-
cal mitosis are evident (H&E, 400X), c. Sheets of malignant epithelial cells showing a central area of necrosis (H&E, 
200X). d, Islands of well-defined malignant epithelium, with flattened peripheral cells separated by collagenized 
stroma. The islands are frequently separated from the adjacent stroma, suggesting a poor adherence of epithelium/
stroma adherence interface (H&E, 200X).
the central epithelial cells, while two cases showed total 
or partial loss of CK5 in most areas, being positive only 
in a few more differentiated islands still showing amel-
oblastic characteristics (Fig. 4d). Expression of CK14 
was also variable in intensity and localization, with 5 
cases presenting positive expression in most of the cells, 
while in 4 it was either negative or focally positive (Fig. 
4e). CK19 expression was not uniform, showing areas 
strongly positive mainly in a few islands with amelob-
lastic characteristics (Fig. 4f). Two cases of AC were 
focally positive for CK7 and CK8.
CD138 was strongly positive in most cases, except in 
very undifferentiated areas where its expression was 
lost or it was weakly positive (Fig. 4g). Expression of E-
cadherin was variable both in intensity and localization 
(Fig. 4h). β-catenin expression was weak or negative 
in all but one case (Fig. 4i). Main immunoprofile and 
comparison between ameloblastomas and ameloblastic 
carcinoma are shown in table 2.
Discussion
AMs are locally aggressive benign tumors with a rela-
tively high risk of recurrence and potential to malignant 
transformation into AC. Up to date, there are around 
120 cases of AC reported in the English literature, some 
of which seem to have developed from AM (4-5). Ra-
diographically, AM may appear either as uni or multi-
locular osteolytic lesions that frequently produce cor-
tical expansion. If paresthesia, pain, irregular borders 
and invasion of adjacent structures are present, then a 
malignant lesion should be suspected (2,6). 
In contrast to AM, ACs usually present microscopic 
evidence of malignancy, but confirmation of the diag-
nosis of a secondary type of AC (those developed from 
a pre-existent AM) need to be supported by a history of 
persistent or recurrent AM, or the presence of benign 
residual areas of AM; eventually, differential diagnosis 
between these two lesions can be difficult, particularly 
in incisional biopsies, and therefore other types of intra-
osseous carcinomas of the jaws should be considered. 
Immunohistochemistry is not usually employed to as-
sist diagnosis and classification of odontogenic tumors, 
but some immunomarkers may be useful for a better 
understanding of their origin and possible biological 
behavior, and therefore the immunohistochemical pro-
file of these lesions may sometimes be helpful to reach 
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Fig. 4: Main immunohistochemical features in ameloblastic carcinoma: a. Epithelial cells showing strong and high expression of 
Ki-67 in most of the cells (200X), b. Nuclear expression of p53 in AC, positive cells are evident, but the intensity of the staining is 
weak (200X), c. p63 immunostaining in ameloblastic carcinoma, with most of the nuclei strongly positive (200X), d. Strong and 
homogenous expression of CK5 in AC, both in the central and peripheral cells of the epithelial islands, with loss of expression in 
focal areas (200X), e. Neoplastic islands illustrating strong expression for CK14 in most cells, but loss of staining or weak expres-
sion in focal regions (200X), f. CK19 staining in ameloblastic carcinoma, showing strongly positive cells permeated by negative 
cells in both peripheral and central areas (200X), g. epithelial malignant sheet showing most cells with strong positivity for CD138 
(400X), h. Case of AC strongly expressing E-cadherin in most of the cells; nevertheless, expression was variable in most cases, 
and some were negative (200X), i. Case of AC showing strong expression of β-catenin. In most cases it was weakly positive or 
negative (200X).
a correct diagnosis in doubtful situations. The present 
series confirms that Ki-67 proliferative index (P=.001) 
and p53 expression (P=.004) are higher in ACs than in 
AMs. These results confirm that Ki-67 immunoexpres-
sion is a useful tool to distinguish among benign and 
malignant tumors, as it has been demonstrated in the 
malignant areas of other tumors, such as carcinoma ex-
PA with scant areas of malignancy that are not clearly 
evident under H&E stained sections (7-8). The higher 
expression of p53 found in ACs as compared to AMs 
suggest that this protein may play a role in malignant 
transformation, as has been also suggested by other 
authors (9-11). However, data regarding p53 expression 
in ACs varies in different studies; for example, stud-
ies performed by Yoon et al., (2); Karakida et al., (12); 
Matsuzaki et al. (10), and Nobusawa et al., (13) de-
scribed p53 overexpression in almost all tumor cells of 
the carcinoma component, while it was negative in the 
benign ameloblastic areas; however, Abiko et al. (14) 
found that both benign and malignant areas of one case 
of AC were negative for p53 by immunohistochemistry. 
In our opinion the information obtained in a single case 
is not enough to compare with our findings, and with 
those found by the other authors that based their studies 
in series of cases that have followed a similar sample 
processing and analysis, with less probabilities of mis-
diagnosis and technical errors.  
It is well known that CKs 14 and 19 are regularly ex-
pressed in the epithelium of the dental germ, where 
CK14 is found in the diverse components during all 
stages of tooth development, including the dental lam-
ina, the inner enamel epithelium and in almost all cells 
of the enamel organ, while CK19 is mainly positive in 
the later stages of development, during terminal differ-
entiation of ameloblasts (15,16). We found a similar pat-
tern of expression of these proteins in AM, but it was 
different to the one observed in AC since in the malig-
nant tumor the expression was irregular in intensity and 
location for both CKs. CKs 5, which was less expressed 
in AC than in AM and CK14 seem to be the major CKs 
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Marker Ameloblastoma (AM) Ameloblastic Carcinoma (AC) 
Ki-67 Expression in basal and suprabasal cells. 
Occasional in central areas. (2.37%) 
Highest expression in basal and suprabasal cells. 
(23.46%) 
p53 Weak expression in basal and suprabasal 
cells. Focal in central areas. (1.77%) 
High expression in basal and suprabasal cells, 
but the nuclei were much less intensely stained. 
(36.01%) 
p63 Positive mainly in the columnar cells of the 
peripheral layer while in the central areas was 
variable. Squamous metaplasias were positive 
in most cases. 
Strong positiveness in most cases and in most of 
the cells. 
CK5 Strong expression in the central areas of the 
epithelial islands and weak or negative in the 
peripheral columnar cells except in the cells 
with flattened and cuboidal aspect. 
Strongly positive at the periphery or within the 
central epithelial cells, while two cases showed 
total or partial loss in most areas. 
CK14 Weak and diffuse expression in the central 
areas, while weak or negative in focal areas 
with squamous metaplasia. 
Variable in intensity and localization, with 5 
cases presenting positive expression in most of 
the cells, while in 4 it was either negative or 
focally positive. 
CK19 Strong expression in the central areas and 
weak or negative in the peripheral columnar 
cells except in the cells with flattened and 
cuboidal aspect. 
It was not uniform, showing areas strongly 
positive, mainly in a few islands with 
ameloblastic characteristics 
CD138 Higher expression in the basal and suprabasal 
layers 
Strongly positive in most cases, except in very 
undifferentiated areas where its expression was 
lost or it was weakly positive 
E-cad Higher positivity in basal and suprabasal cells 
than those located in the central areas. In 
squamous metaplasia focal cells were 
strongly positive. 
Variable either in intensity or localization, with 
some cases being strongly positive in focal areas 
while others were considered negative. 
Ǻ-cat Weakly positive in most cases, except in 
areas with squamous metaplasia, where 
expression was more evident. 
Weak or negative in all cases. 


Table 2: Comparison of the main immunohistochemical features of 15 cases of ameloblastomas and 9 cases of ameloblastic 
carcinomas observed in this series.
expressed by epithelium in the human enamel organ, 
marking the end of secretion of amelogenin (17).
CK8 is found in embrionary and several simple epithe-
lia, as well as in the human enamel organ, but Crivellini 
et al., concluded that CK8 was absent in odontogenic 
epithelium, as it was observed in most cases in our 
study.
CK19 expression has been demonstrated in most odon-
togenic cysts and benign tumors, and it has been consid-
ered a good marker for benign odontogenic lesions (14). 
Nevertheless it is also expressed in AC and therefore 
has no diagnostic utility to differentiate among these 
entities (18,19). In the present study, CK19 expression 
in AC was variable, being usually maintained in areas 
with ameloblastic characteristics. 
p63 is expressed in normal epithelium and it is often 
overexpressed in carcinomas, including oral squamous 
cell carcinoma (20). It is also overexpressed in odon-
togenic carcinomas, such as AC, primary intraosseous 
squamous cell carcinoma and clear cell carcinoma as 
compared to benign odontogenic lesions, suggesting 
that p63 may have a role in tumorigenesis of odontogen-
ic lesions (21). In the present study, p63 was mainly ex-
pressed in the basal and suprabasal cells of AM, in a 
pattern previously observed in odontogenic keratocyst, 
suggesting that this protein is a good marker of more 
immature keratinocytes (22). Different from AM, p63 
was overexpressed in all our cases of AC, labeling most 
of the cells, in a similar way as it occur in other types of 
carcinomas, indicating lack of cell differentiation and a 
higher potential for growth, two common characteris-
tics of malignancies (23). 
Cell adhesion molecules and their interactions can be 
altered in tumors, particularly in malignancies, favor-
ing progression, invasion, recurrence and metastasis 
(5). In normal conditions, E-cadherin is moderately ex-
pressed in odontogenic epithelium during the bell stage, 
especially in the stellate reticulum of the enamel organ, 
and also in the polyhedral cells of ameloblastomas (24). 
β-catenin is a multifunctional molecule that plays a role 
in cell-cell adhesion mediated by classic cadherins as 
well as in Wnt-signaling (25). CD138 is a cell surface 
proteoglycan present in normal epithelial cells, whose 
expression seems to decrease in ameloblastomas, as 
compared to epithelial cells of normal enamel organ, 
having also an inverse relation with cell proliferation 
index, aggressiveness and recurrence (26-28). There are 
some studies that have demonstrated positive expres-
sion of CD138 in AM, both in the columnar and the 
polyhedral cells of the stellate reticulum (29), and nu-
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clear expression of E-cadherin and β-catenin have been 
reported in cases of solid AM and odontogenic carcino-
mas (25). In this study, CD138 was the most strongly ex-
pressed adhesion molecule, both in AM and AC, while 
E-cadherin and β-catenin expression was faint in most 
of the cases. These last two markers were intensely 
positive only in areas of squamous metaplasia of AMs, 
particularly when desmosomes were evident in H&E 
stained preparations. CD138 expression was faint or 
negative only in the central areas of AMs islands where 
cells were loosely adhered, leaving spaces between 
them. CD138 was positive in most areas of AC, except 
in the less differentiated regions, where expression was 
decreased or lost. However, our data does not allow us 
to confirm that there is a higher loss of these molecules 
in AC as compared to AM, and therefore more stud-
ies are necessary to determine if loss of expression of 
these proteins can be relevant to support malignant 
transformation or higher aggressiveness in these neo-
plasms. As mentioned above, expressions of E-cadherin 
and β-catenin were weak in AMs and ACs, difficulting 
analysis about their possible role in these neoplasms.
In summary, the results of this work confirmed that 
patients with AC were about a decade older than those 
with AM. Ki-67 and p53 immunoexpression was higher 
in AC than in AM, supporting the idea that they can 
be good markers of malignant transformation. p63 was 
also more frequently expressed in AC, suggesting loss 
of maturation of the malignant epithelial cells. The pat-
tern of expression of CKs 5 and 19 is altered in AC in 
relation to AM, but this does not seem to be related to 
malignant transformation. Finally, we could not find ev-
ident loss of the adhesion molecules CD138, E-cadherin 
and β-catenin in AC in relation to AM, but as ACs are 
very rare lesions, we suggest that new series of cases 
need to be studied for a better understanding of its clini-
cal and biological aspects.
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